• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

交流预后信息:无法治愈的癌症患者应该被告知什么?肿瘤医生是怎么想的?

Communicating prognostic information: what do oncologists think patients with incurable cancer should be told?

机构信息

NHMRC Clinical Trials Centre, University of Sydney, Sydney, New South Wales, Australia.

出版信息

Intern Med J. 2020 Dec;50(12):1492-1499. doi: 10.1111/imj.14739.

DOI:10.1111/imj.14739
PMID:31904887
Abstract

BACKGROUND

People with incurable cancer require information about their prognosis to make informed decisions about their future.

AIMS

To determine the frequency, form and documentation of prognostic discussions between oncologists and their patients with incurable cancer.

METHODS

We surveyed medical oncologists in Australia and New Zealand about their practices communicating prognosis.

RESULTS

A total of 206 medical oncologists completed the survey. Respondent characteristics were: median age 40 years (range 27-75), female 51%, trainee 22%; and 71% had completed specific training on communicating prognosis. Respondents reported discussing prognosis with a patient a median of 10 times per month (interquartile range 4-15); 88% reported explaining that 'the cancer is incurable' to all their patients with incurable cancer and 84% reported always or usually providing a quantitative estimate of survival time. The preferred method for explaining expected survival time (EST) was providing 'multiple ranges of time with probabilities, for example best-case, typical and worst-case scenarios' (52% of respondents). The most frequently reported barriers to discussing EST were: 'family members requesting that prognostic information not be discussed' (57% of respondents), and 'not knowing the EST' (46% of respondents). Twenty percent reported always documenting prognostic discussions and the EST in the patient's medical record, and 11% reported always documenting this information in their letters to other doctors.

CONCLUSIONS

Most oncologists reported providing quantitative estimates of EST to their patients with incurable cancer, but very few reported documenting this information. Methods to help oncologists estimate, explain and document survival time are needed to improve communication of prognosis.

摘要

背景

患有绝症的人需要了解自己的预后信息,以便就未来做出明智的决策。

目的

确定绝症患者的肿瘤医生与其进行预后讨论的频率、形式和记录情况。

方法

我们调查了澳大利亚和新西兰的肿瘤医生在预后沟通方面的实践情况。

结果

共有 206 名肿瘤医生完成了这项调查。受访者的特征为:中位年龄 40 岁(范围 27-75 岁),女性占 51%,实习生占 22%;71%的人接受过专门的预后沟通培训。受访者报告称,每月中位数讨论 10 次与患者的预后情况(四分位距 4-15);88%的人报告向所有患有绝症的患者解释“癌症是无法治愈的”,84%的人报告始终或通常提供生存时间的定量估计。解释预期生存时间(EST)的首选方法是提供“带有概率的多个时间范围,例如最佳情况、典型情况和最差情况”(52%的受访者)。讨论 EST 时最常报告的障碍包括:“家属要求不讨论预后信息”(57%的受访者)和“不知道 EST”(46%的受访者)。20%的受访者报告始终将预后讨论和 EST 记录在患者的病历中,11%的受访者报告始终将这些信息记录在给其他医生的信中。

结论

大多数肿瘤医生报告向患有绝症的患者提供 EST 的定量估计,但很少有医生报告记录这些信息。需要有方法帮助肿瘤医生估计、解释和记录生存时间,以改善预后沟通。

相似文献

1
Communicating prognostic information: what do oncologists think patients with incurable cancer should be told?交流预后信息:无法治愈的癌症患者应该被告知什么?肿瘤医生是怎么想的?
Intern Med J. 2020 Dec;50(12):1492-1499. doi: 10.1111/imj.14739.
2
Doctor-to-doctor communication of prognosis in metastatic cancer: a review of letters from medical oncologists to referring doctors.转移性癌症预后的医患沟通:肿瘤内科医生致转诊医生信件综述
Intern Med J. 2015 Sep;45(9):909-15. doi: 10.1111/imj.12776.
3
Accuracy and Prognostic Significance of Oncologists' Estimates and Scenarios for Survival Time in Advanced Gastric Cancer.胃癌晚期生存时间预测:肿瘤学家预测和设想的准确性及其预后意义。
Oncologist. 2019 Nov;24(11):e1102-e1107. doi: 10.1634/theoncologist.2018-0613. Epub 2019 Apr 1.
4
How Do Blood Cancer Doctors Discuss Prognosis? Findings from a National Survey of Hematologic Oncologists.血液癌症医生如何讨论预后?一项对血液肿瘤学家的全国性调查结果。
J Palliat Med. 2019 Jun;22(6):677-684. doi: 10.1089/jpm.2018.0441. Epub 2019 Mar 23.
5
Disarming the guarded prognosis: predicting survival in newly referred patients with incurable cancer.消除预后的不确定性:预测新转诊的不可治愈癌症患者的生存情况。
Br J Cancer. 2006 Jan 30;94(2):208-12. doi: 10.1038/sj.bjc.6602908.
6
What are terminally ill cancer patients told about their expected deaths? A study of cancer physicians' self-reports of prognosis disclosure.对于身患绝症的癌症患者,他们被告知的关于预期死亡的情况是怎样的?一项关于癌症医生预后披露自我报告的研究。
J Clin Oncol. 2008 Dec 20;26(36):5988-93. doi: 10.1200/JCO.2008.17.2221. Epub 2008 Nov 24.
7
Communicating with realism and hope: incurable cancer patients' views on the disclosure of prognosis.带着现实与希望进行沟通:晚期癌症患者对预后告知的看法
J Clin Oncol. 2005 Feb 20;23(6):1278-88. doi: 10.1200/JCO.2005.11.138.
8
Prognosticating for Adult Patients With Advanced Incurable Cancer: a Needed Oncologist Skill.预测晚期不可治愈癌症成年患者的预后:肿瘤医生所需的技能。
Curr Treat Options Oncol. 2020 Jan 16;21(1):5. doi: 10.1007/s11864-019-0698-2.
9
Estimating survival in advanced cancer: a comparison of estimates made by oncologists and patients.评估晚期癌症患者的生存情况:肿瘤学家和患者的评估比较。
Support Care Cancer. 2020 Jul;28(7):3399-3407. doi: 10.1007/s00520-019-05158-5. Epub 2019 Nov 28.
10
Mismatch between Pediatric Oncologists' Private and Parent-Facing Prognostic Communication: Communication Patterns Used to Soften Prognostic Disclosure.儿科肿瘤学家在私下与面对家长时的预后沟通之间存在差异:用于缓和预后披露的沟通模式。
J Palliat Med. 2023 Feb;26(2):210-219. doi: 10.1089/jpm.2022.0265. Epub 2022 Aug 17.

引用本文的文献

1
Delivering improved survivorship care for people affected by advanced or metastatic cancer.为罹患晚期或转移性癌症的患者提供更好的癌症康复护理。
Acta Oncol. 2024 Dec 9;63:939-942. doi: 10.2340/1651-226X.2024.42197.
2
Timing of prognostic discussions in people with advanced cancer: a systematic review.晚期癌症患者预后讨论时机的系统评价。
Support Care Cancer. 2024 Jan 23;32(2):127. doi: 10.1007/s00520-023-08230-3.
3
Using three scenarios to explain life expectancy in advanced cancer: attitudes of patients, family members, and other healthcare professionals.
用三个场景来解释晚期癌症患者的预期寿命:患者、患者家属和其他医疗保健专业人员的态度。
Support Care Cancer. 2022 Sep;30(9):7763-7772. doi: 10.1007/s00520-022-07167-3. Epub 2022 Jun 15.
4
Helping Patients Communicate With Oncologists When Cancer Treatment Resistance Occurs to Develop, Test, and Implement a Patient Communication Aid: Sequential Collaborative Mixed Methods Study.当癌症治疗出现耐药时帮助患者与肿瘤学家沟通:开发、测试和实施患者沟通辅助工具的序贯协作混合方法研究。
JMIR Res Protoc. 2022 Jan 12;11(1):e26414. doi: 10.2196/26414.
5
Communication about Prognosis during Patient-Initiated Second Opinion Consultations in Advanced Cancer Care: An Observational Qualitative Analysis.晚期癌症护理中患者发起的二次意见咨询期间关于预后的沟通:一项观察性定性分析
Int J Environ Res Public Health. 2021 May 26;18(11):5694. doi: 10.3390/ijerph18115694.
6
When Should Oncologists Use the Words and ?肿瘤学家何时应使用“和”这个词?
JNCI Cancer Spectr. 2020 Aug 14;4(6):pkaa066. doi: 10.1093/jncics/pkaa066. eCollection 2020 Dec.